A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer (BCCR)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
RATIONALE: Gathering information about patients with breast cancer and their families may help the study of breast cancer in the future.
PURPOSE: This clinical trial is gathering information about patients with breast cancer and their families.
| Condition | Intervention |
|---|---|
|
Breast Cancer Precancerous Condition |
Other: medical chart review Other: questionnaire administration Other: study of socioeconomic and demographic variables Procedure: Excess human biological tissue Procedure: quality-of-life assessment |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Development and Implementation of The Breast Cancer Collaborative Registry (BCCR) |
- Implementation of a web-based Breast Cancer Collaborative Registry at the National Comprehensive Cancer Network (NCCN) centers [ Time Frame: Ongoing ] [ Designated as safety issue: No ]Web-based registry
- Merger of data collected under the Adult Oncology Data Collection Study and the National Comprehensive Cancer Network Data Coordinating study at UNMC/NMC [ Time Frame: Ongoing ] [ Designated as safety issue: No ]Web-based registries.
- Standardization of clinical, environmental, socio-demographic, and family history data collected for breast cancer-related research and shared by the Eppley Breast Cancer Research Group collaborators [ Time Frame: Ongoing ] [ Designated as safety issue: No ]Web-based registry.
Biospecimen Retention: Samples With DNA
Tissue, blood
| Estimated Enrollment: | 999999 |
| Study Start Date: | October 2006 |
| Estimated Primary Completion Date: | December 2020 (Final data collection date for primary outcome measure) |
-
Other: medical chart review
OBJECTIVES:
- To develop a web-based Breast Cancer Collaborative Registry (BCCR) as a repository for socio-demographic, environmental, clinical history, family history, and biospecimen data collected at the National Comprehensive Cancer Network (NCCN) centers for participants with a personal history of breast cancer and/or characteristics of hereditary breast cancer.
- To merge the data already being collected on breast cancer patients under the Adult Oncology Data Collection Study and newly diagnosed breast cancer patients participating in the NCCN Data Coordinating study at UNMC/NMC.
- To standardize clinical, environmental, socio-demographic, and family history data for breast cancer-related information to be collected and shared for research purposes by Eppley Breast Cancer Research Group breast cancer research collaborators.
- To collect, validate, and disseminate the breast cancer-related data to establish a high-risk cohort for future research into the molecular and biological bases of breast cancer susceptibility and interventional trials.
OUTLINE: This is a multicenter study.
Study participants undergo data collection related to breast cancer studies at one of the National Comprehensive Cancer Network (NCCN) centers for inclusion in the Breast Cancer Collaborative Registry (BCCR). The BCCR is a comprehensive computerized database that serves as a repository for socio-demographic, environmental, clinical history, family history, and biospecimen data collected for breast cancer patients treated on UNMC protocols. Central features of the registry include standardized data-entry forms and a relational database that can be used as a resource for the study of the pathology, immunology, cytogenetics, molecular biology, epidemiology, clinical features, and outcome of patients with benign, pre-malignant, or malignant breast disease.
Study participants complete a self-administered electronic or paper-based survey and a medical history questionnaire at baseline to provide information on demographics (e.g., age and sex); personal and family medical history; treatment history; lifestyle, physical activity, and dietary habits; quality of life; environmental exposure history; and the family tree for inclusion in the registry. Participants also undergo telephone or in-person structured interviews conducted by study coordinators, genetic counselors, or the System Coordinator of the BCCR to provide additional information or clarification of the information provided in the questionnaires.
Study participants also undergo review of their medical records and pathology reports to obtain detailed medical and treatment-related information for inclusion in the registry. The information collected includes retrospective and prospective disease-specific data (e.g., diagnosis, grade/stage, and laboratory values) and longitudinal outcome data (e.g., response to treatment, toxicity, survival, relapse) derived during prospective clinical follow-up.
Study participants are followed periodically to update relevant health and family histories.
Eligibility| Ages Eligible for Study: | 19 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
- Adult individuals (male and female) who have a personal diagnosis/history of breast cancer, atypical hyperplasia, ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS) (as stated in the NCCN Breast and/or Ovarian Genetic Assessment Guidelines v.1.2006 (Appendix A)
- Adult individuals who have characteristics of hereditary breast cancer, as defined in the NCCN Breast and/or Ovarian Genetic Assessment Guidelines v.1.2006 (Appendix A) or who have a breast cancer risk of > 1.67% over 5 years as estimated by GAIL Model (Appendix C )
- Age 19 or greater
- Able to provide informed consent
DISEASE CHARACTERISTICS:
-
Recruited by a participating physician and meets at least 1 of the following criteria:
- Current diagnosis or history of breast cancer, atypical hyperplasia, ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS) as defined in the National Comprehensive Cancer Network Breast and/or Ovarian Genetic Assessment Guidelines, v.1.2006
- Characteristics of hereditary breast cancer, as defined in the National Comprehensive Cancer Network Breast and/or Ovarian Genetic Assessment Guidelines, v.1.2006 (relatives have been diagnosed with breast and/or ovarian cancer) OR have a breast cancer risk of > 1.67% over 5 years as estimated by the GAIL Model
- Hormone receptor status not specified
PATIENT CHARACTERISTICS:
- Male or female
- Menopausal status not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00666731
| Contact: Michelle Desler, MS | 402-559-8885 | mdesler@unmc.edu | |
| Contact: Marsha Ketcham, RN OCN | 402-559-5286 | mketcham@unmc.edu |
| United States, Colorado | |
| Penrose Cancer Center | Recruiting |
| Colorado Springs, Colorado, United States, 80907 | |
| Contact: Jodi Harr 719-776-5270 jodiharr@centura.org | |
| Principal Investigator: Kate Crow, MS CGC | |
| United States, Iowa | |
| Abben Cancer Center | Recruiting |
| Spencer, Iowa, United States, 51301 | |
| Contact: Jolyn Threlkeld, RN 712-264-8691 jthrelkeld@spencerhospital.org | |
| Principal Investigator: Glenn Preston | |
| United States, Massachusetts | |
| Holyoke Medical Center | Recruiting |
| Holyoke, Massachusetts, United States, 01040 | |
| Contact: Lynn Downey, RHIT, CTR 413-534-2500 downey_lynn@holyokehealth.com | |
| Principal Investigator: Zubeena Mateen, M.D. | |
| St. Vincent Hospital | Recruiting |
| Worcester, Massachusetts, United States, 01608 | |
| Contact: Pamela Sigel, R.N. 508-363-7018 pam.sigel@stvincenthospital.com | |
| Contact: Enzo Centofanti, Exec Dir enzo.centofanti@stvincenthospital.com | |
| Principal Investigator: James Rooney, M.D. | |
| United States, Nebraska | |
| Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center | Recruiting |
| Grand Island, Nebraska, United States, 68803 | |
| Contact: Rebecca Hadenfeldt 308-398-6518 rhadenfeldt@sfmc-gi.org | |
| Contact: Mary Gulzow 308-398-6518 | |
| Principal Investigator: Mehmet Copur, M.D. | |
| Mary Lanning Healthcare/Morrison Cancer Center | Recruiting |
| Hastings, Nebraska, United States, 68901 | |
| Contact: Viola Burkett, RN 402-460-5899 viola.burkett@marylanning.org | |
| Principal Investigator: Shamila Garg, MD | |
| Good Samaritan Hospital/Cancer Center | Recruiting |
| Kearney, Nebraska, United States, 68847 | |
| Contact: Judy Mullen, LPN 308-865-7564 judymullen@catholichealth.net | |
| Contact: Connie Wittman | |
| Principal Investigator: George Bascom, M.D. | |
| St. Elizabeth's Regional Medical Center | Recruiting |
| Lincoln, Nebraska, United States, 68510 | |
| Contact: Michelle Broman, R.N. 402-219-7912 mbroman@stez.org | |
| Contact: Karen Pribnow, RN, BSN, OCN 402-219-7912 kpribnow@stez.org | |
| Principal Investigator: Kevin Yiee, M.D. | |
| Great Plains Regional Medical Center | Recruiting |
| North Platte, Nebraska, United States, 69101 | |
| Contact: Lisa Kosmacek 308-696-7386 kosmacekl@gmhealth.org | |
| Principal Investigator: Irfan Vaziri, MD | |
| UNMC Eppley Cancer Center at the University of Nebraska Medical Center | Recruiting |
| Omaha, Nebraska, United States, 68198-6805 | |
| Contact: Michelle Desler, MS 402-559-8885 mdesler@unmc.edu | |
| Contact: Alice Kueh, Coordinator 402-559-8511 akueh@unmc.edu | |
| Principal Investigator: Kenneth Cowan, M.D., Ph.D. | |
| Regional West Health Services | Recruiting |
| Scottsbluff, Nebraska, United States, 69361 | |
| Contact: Michele Lambert, RN 308-630-2429 michele.lambert@rwmc.net | |
| Principal Investigator: Vince Bjorling, MD | |
| United States, North Dakota | |
| Trinity Hospital Cancer Care Center | Recruiting |
| Minot, North Dakota, United States, 58701 | |
| Contact: Nadia Smetana 701-857-3174 nadia.smetana@trinityhealth.org | |
| Principal Investigator: Michael Grant, MD | |
| United States, South Dakota | |
| Avera Medical Group Oncology and Hematology Aberdeen | Recruiting |
| Aberdeen, South Dakota, United States, 57401 | |
| Contact: Cari Price, RN 605-622-5613 cari.price@avera.org | |
| Principal Investigator: Richard Conklin, MD | |
| Avera Cancer Institute | Recruiting |
| Mitchell, South Dakota, United States, 57301 | |
| Contact: Joni Sevigny 605-995-5725 joni.sevigny@avera.org | |
| Contact: Bonnie Hoffman, RN 605-995-5725 bonnie.hoffman@avera.org | |
| Principal Investigator: Stephen J Dick, MD | |
| Regional Cancer Care Institute | Recruiting |
| Rapid City, South Dakota, United States, 57701 | |
| Contact: Amy Boylan 605-755-2325 amy.boylan@avera.org | |
| Principal Investigator: Daniel Petereit, MD | |
| Avera Cancer Center | Recruiting |
| Sioux Falls, South Dakota, United States, 57105 | |
| Contact: Heidi Nickles 605-322-3095 heidi.nickles@avera.org | |
| Contact: Cheryl Ageton, RN, CCRC cheryl.ageton@avera.org | |
| Principal Investigator: Amy Krie, M.D. | |
| Principal Investigator: | Kenneth H. Cowan, MD, PhD | University of Nebraska |
More Information
Additional Information:
No publications provided
| Responsible Party: | University of Nebraska |
| ClinicalTrials.gov Identifier: | NCT00666731 History of Changes |
| Other Study ID Numbers: | 311-06, P30CA036727, UNMC-31106 |
| Study First Received: | April 24, 2008 |
| Last Updated: | March 10, 2015 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Nebraska:
|
male breast cancer breast cancer ductal breast carcinoma in situ lobular breast carcinoma in situ atypical ductal breast hyperplasia |
Additional relevant MeSH terms:
|
Breast Neoplasms Precancerous Conditions Breast Diseases |
Neoplasms Neoplasms by Site Skin Diseases |
ClinicalTrials.gov processed this record on April 27, 2015